Search

Your search keyword '"Lorusso V"' showing total 1,088 results

Search Constraints

Start Over You searched for: Author "Lorusso V" Remove constraint Author: "Lorusso V"
1,088 results on '"Lorusso V"'

Search Results

1. Considering renal risk while managing cancer

2. Management of chemotherapy-induced nausea and vomiting by risk profile: role of netupitant/palonosetron

5. Organ preservation and oncological efficacy of peniscopically controlled CO2 laser excision of penile squamous cell carcinoma: Early and late results in a high-volume center

6. Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study

8. Bilateral inguinal lymph-node dissection versus unilateral inguinal lymph-node dissection and contralateral dynamic sentinel node biopsy in clinical N1 squamous cell carcinoma of the penis

11. The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

13. Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

14. Adenosine pathway inhibitors: novel investigational agents for the treatment of metastatic breast cancer

20. Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

21. Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE

23. Pelvectomie antérieure robot-assistée avec préservation sexuelle

25. La résection trans-urétrale de vessie de réévaluation est-elle toujours nécessaire en cas de primo-résection sous luminofluorescence par hexaminolévulinate ?

28. Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?

30. Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study

32. A Novel Artificial Urinary Sphincter (VICTO) for the Management of Postprostatectomy Urinary Incontinence: Description of the Surgical Technique and Preliminary Results from a Multicenter Series.

33. The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

41. P090 - Analysis of Urinary Tract Infections (UTI) complications after radical cystectomy: Results from a single center study and improvement of ERAS protocol.

42. Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme

43. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

44. Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

45. Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

46. Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

50. Combined anterior and posterior approach robot-assisted resection of a giant and complex abdominoperineal angiomyofibroblastoma in a male patient

Catalog

Books, media, physical & digital resources